Table 2. Results of overall analysis and subgroup analysis in this meta-analysis.
Group | Dominant model | Additive model | Recessive model |
Ethnicity | |||
Caucasian | 1.13 (0.90–1.41) | 1.02 (0.96–1.08) | 1.08 (0.92–1.27) |
African-American | 1.09 (0.75–1.58) | 1.24 (1.05–1.47) | 0.56 (0.30–1.03) |
Mixed | 1.10 (1.01–1.21) | 1.07 (0.96–1.18) | 0.95 (0.84–1.09) |
Menopausal status | |||
Premenopausal | 1.90 (0.73–4.91) | 1.08 (0.98–1.19) | 2.24 (0.48–10.35) |
Postmenopausal | 0.98 (0.86–1.12) | 0.93 (0.86–1.01) | 1.02 (0.87–1.21) |
Genotyping method | |||
PCR-RFLP | 1.27 (1.08–1.49) | 1.15 (1.02–1.29) | 0.90 (0.70–1.17) |
TaqMan Real Time PCR | 1.08 (0.96–1.22) | 1.04 (1.00–1.13) | 0.93 (0.72–1.20) |
MassARRAY Sequenome | 0.83 (0.68–1.02) | 0.98 (0.88–1.09) | 0.97 (0.83–1.13) |
Control source | |||
Population | 1.14 (1.02–1.28) | 1.09 (1.01–1.18) | 0.95 (0.80–1.13) |
Hospital | 1.03 (0.83–1.29) | 1.00 (0.89–1.10) | 0.95 (0.82–1.10) |
Overall OR | 1.12 (1.02–1.24) | 1.07 (1.01–1.14) | 0.95 (0.84–1.09) |